Insights
Gain perspectives from experts on various policy issues and therapeutic areas through our Insights series that engages multiple managed care stakeholders in video interviews.
February 24, 2020 –
Viviana Figueroa Diaz, MD, reviews risk factors commonly associated with nonalcoholic steatohepatitis and advanced fibrosis caused by nonalcoholic steatohepatitis, including genetic predisposition and obesity.
February 24, 2020 –
Norman Sussman, MD, defines nonalcoholic steatohepatitis and advanced fibrosis and comments on the role of early detection to prevent more serious complications such as cirrhosis.
February 21, 2020 –
Jose Martinez, MD, and Robert Wong, MD, review treatment plans for patients with mild, moderate, and more severe forms of diabetic retinopathy.
February 21, 2020 –
Educating patients to prevent or delay progression of diabetic retinopathy by glycemic control of their diabetes and lifestyle modifications.
February 14, 2020 –
Experts discuss the clinical and economic burden of illness in patients with mild and severe diabetic retinopathy and its effect on the patients’ QoL.
February 14, 2020 –
Progressive nature of diabetic retinopathy and the complications that arise from DR in the advanced stages.
February 07, 2020 –
Robert Wong, MD, emphasizes the relevance of comprehensive eye evaluation and other tests to be considered when detecting diabetic retinopathy.
February 07, 2020 –
Jose Martinez, MD, discusses the testing for early detection of diabetic retinopathy and the frequency at which these tests should be performed.
January 31, 2020 –
Prevalence of diabetic retinopathy in patients with type 1 and type 2 diabetes along with the most common signs and symptoms.
December 24, 2019 –
Jose Martinez, MD, provides a brief overview of diabetic retinopathy (DR) and the risk factors associated with it.
